Imidapril

This classification denotes an ace inhibitor, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier BW7H1TJS22. European Medicines Agency schedules Imidapril in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08143MIG. Imidapril generally arises in the molecular formula C20H27N3O6. The term IMIDAPRIL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 3, no. 3, 1989, list 29.) IMIDAPRIL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule imidapril under HS 29332990 and SITC 51573. As of Q4 2014, IMIDAPRIL remains the US FDA Preferred Term for this commodity. Imidapril bears US NLM identifiers UMLS ID C0165703 and NCI Concept Code C72908. SMILES: O=C(N1C(CN(C1=O)C)C(=O)O)C(NC(CCc1ccccc1)C(=O)OCC)C.